✨ 4 results found - Searched 21766 records in 3ms.
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_status-fungsional-rasio-limfosit-monosit-dan-rasio-trombosit-limfosit-20240201135629.jpg&width=120)
Tesis
Status Fungsional, Rasio Limfosit Monosit dan Rasio Trombosit Limfosit sebagai Faktor Prognosis Kesintasan Satu Tahun Pasien Lanjut Usia dengan Kanker Paru Karsinoma Bukan Sel Kecil Stadium IIIB-IV
2024 | BY Ratna Nurhayati - Aulia Rizka - Noorwati Sutandyo - Cleopas Martin Rumende- Functional Status, Lymphocyte to Monocyte Ratio and Platelet to Lymphocyte Ratio as a Prognostic Factor of 1-year Survival in Elderly with Non-Small Cell Lung Stage IIIB-IV.
- Nomor Panggil T24053fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_hitung-jenis-leukosit-sebagai-prediktor-neutropenia-akut-awitan-pertam-20231117101758.jpg&width=120)
Tesis
Hitung Jenis Leukosit sebagai Prediktor Neutropenia Akut Awitan Pertama Pascakemoterapi R-CHOP pada Pasien Diffuse Large B-cell Lymphoma
2019 | BY Griskalia Christine - Lugyanti Sukrisman - Noorwati Sutandyo - Cleopas Martin Rumende- Differential Count of Leukocytes as A Predictor of The First Onset Acute Neutropenia After R-CHOP Chemotherapy in Diffuse Large B-cell Lymphoma Patients.
- Nomor Panggil T19185fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_perubahan-kapasitas-fungsional-mengunakan-uji-jalan-6-menit-dan-peruba-20231112112746.jpeg&width=120)
Tesis
Perubahan Kapasitas Fungsional Mengunakan Uji Jalan 6 Menit Dan Perubahan Kualitas Hidup Mengunakan EORTC QLQ C-30 pada pasien Kanker payudara Stadium I Sampai III Sebelum Kemoterapi Dan Setelah Kemoterapi Adjuvant ke-3 di RSKD
2016 | BY Noorwati Sutandyo - Leni Onna G.P - Siti Annisa Nuhonni - Martin Rumende - Kumara Bakti Hera Pratiwi- Changes in Functional Capacity Using 6 Minute Walking Test and Quality of Life Using EORTC QLQ C-30 in Patient With Stage I-III Breast Cancer Before And After Third Adjuvant Chemotherapy in RSKD.
- Nomor Panggil T16549fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_perbandingan-rejimen-kemoterapi-cisplatin-etoposide-dengan-cisplatin-d-20221117091610.jpg&width=120)
Tesis
Perbandingan rejimen kemoterapi cisplatin-etoposide dengan cisplatin-docetaxel dalam hal kesintasan 2 tahun dan progression-free survivalpasien kanker paru stadium lanjut jenis non-small cell
2012 | BY Salman Paris Harahap - Noorwati Sutandyo - Cleopas Martin Rumende - Hamzah Shatri- Comparison of chemotherapy effect between cisplatin-etoposide and cisplatin-docetaxed in 2-year survival rate and progression free survival rate of advanced non-small cell lung cancer patients.
- Nomor Panggil T12376fk